Table S1. Primers and oligonucleotides sequences used in this study. (DOCX 15 kb
Table S1. Sequence of miR-214 mimic and negative control. Table S2. Primers used in Real time-PCR te...
Table S1. Top 10 significantly expressed lncRNAs in thyroid cancer. Table S2. Sequences. (DOCX 21â...
Table S1. Analysis of upreguated differential genes in STAD from TCGA. (XLSX 447Â kb
Table S2. Correlation between LINC01133 expressions and clinicopathological parameters in gastric ca...
Figure S1. The expression of LINC01133 in GC patents with different clinical subgroups. a-d Relative...
Figure S3. Predicted target miRNAs of LINC01133 and predicted binding sites for miR-106a-3p in LINC0...
Figure S2. LINC01133 knockdown enhances GC cells motility and LINC01133 overexpression inhibits colo...
Figure S1-S10 (Online). Table S1. The top 10 significantly upregulated and downregulated lncRNAs ide...
Real-time PCR analysis of miR-501-5p in miR-501-5p-overexpressing, miR-501-5p-silenced and control M...
Figure S5. TCGA analysis of the expression levels of miR-193b-5p, miR-542-3p, miR-362-5p and miR-203...
Table S1. Detailed information of cohort 1 and 2 is listed. Table S2. Primers and RNA sequences used...
Table S1. The primer sequences. Table S2. Correlation of circDLST expression with clinicopathologic ...
GO analysis showed that c-myb, cyclinB1/G2, and BCL-6 as downstream regulation elements, were implic...
Table S3. Prediction of binding site that MACC1-AS1 interacts with MACC1 mRNA. Table S4.. Negative b...
Table S1. Primer sequences and siRNAs/shRNA oligonucleotides information. (XLSX 12Â kb
Table S1. Sequence of miR-214 mimic and negative control. Table S2. Primers used in Real time-PCR te...
Table S1. Top 10 significantly expressed lncRNAs in thyroid cancer. Table S2. Sequences. (DOCX 21â...
Table S1. Analysis of upreguated differential genes in STAD from TCGA. (XLSX 447Â kb
Table S2. Correlation between LINC01133 expressions and clinicopathological parameters in gastric ca...
Figure S1. The expression of LINC01133 in GC patents with different clinical subgroups. a-d Relative...
Figure S3. Predicted target miRNAs of LINC01133 and predicted binding sites for miR-106a-3p in LINC0...
Figure S2. LINC01133 knockdown enhances GC cells motility and LINC01133 overexpression inhibits colo...
Figure S1-S10 (Online). Table S1. The top 10 significantly upregulated and downregulated lncRNAs ide...
Real-time PCR analysis of miR-501-5p in miR-501-5p-overexpressing, miR-501-5p-silenced and control M...
Figure S5. TCGA analysis of the expression levels of miR-193b-5p, miR-542-3p, miR-362-5p and miR-203...
Table S1. Detailed information of cohort 1 and 2 is listed. Table S2. Primers and RNA sequences used...
Table S1. The primer sequences. Table S2. Correlation of circDLST expression with clinicopathologic ...
GO analysis showed that c-myb, cyclinB1/G2, and BCL-6 as downstream regulation elements, were implic...
Table S3. Prediction of binding site that MACC1-AS1 interacts with MACC1 mRNA. Table S4.. Negative b...
Table S1. Primer sequences and siRNAs/shRNA oligonucleotides information. (XLSX 12Â kb
Table S1. Sequence of miR-214 mimic and negative control. Table S2. Primers used in Real time-PCR te...
Table S1. Top 10 significantly expressed lncRNAs in thyroid cancer. Table S2. Sequences. (DOCX 21â...
Table S1. Analysis of upreguated differential genes in STAD from TCGA. (XLSX 447Â kb